脉搏波maibobo品牌怎么样 申请店铺

我要投票 脉搏波maibobo在医疗器械行业中的票数:326 更新时间:2025-07-21
脉搏波maibobo是哪个国家的品牌?「脉搏波maibobo」是 深圳瑞光康泰科技有限公司 旗下著名品牌。该品牌发源于广东省深圳市,由创始人吴小光在2008-04-16期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力脉搏波maibobo品牌出海!将品牌入驻外推网,定制脉搏波maibobo品牌推广信息,可以显著提高脉搏波maibobo产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

脉搏波maibobo怎么样

集激光技术、血压测量技术器械等的研发、生产、销售和服务为一体的高科技医疗企业,其脉搏波血压测量法在业内享有盛名


深圳瑞光康泰科技有限公司是一家专业研发、生产、销售激光技术、血压测量技术高科技企业, 拥有一支科研队伍,为产品自主研发和升级提供了强有力的技术支持。

公司自主研发的第四代血压精准测量技术——脉搏波血压测量法,现已获得中国发明专利(专利 号:ZL 2010 1 0247968.6)、日本发明专利(专利号:特许第5591404号)及韩国发明专利(专利 号:10-1460922),并在全球四十余个国家申请了发明专利。

在国内,脉搏波血压测量法已经在北京阜外医院、华中科技大学同济医学院附属协和医院等二十余家大型三甲医院通过临床验证。集团开发的“天天血压”健康管理客户端融合先进互联网技术,依托脉搏波血压计的准确数据,为顾客提供专业的血压健康管理服务。同时脉搏血压计产品已拿到注册证8个型号将近20个。规格涵盖院用、OTC、移动使用、儿童专用。

七年来,瑞光康泰不断拓展市场,在广州、北京等国内二十多个省市设立了营销网络,在国际市场,半导体激光治疗机、脉搏波血压计通过了欧盟CE认证、 出口美国、西班牙等二十多个国家和地区。


A high-tech medical enterprise integrating research and development, production, sales and service of laser technology and blood pressure measuring technology and instruments, Its pulse wave blood pressure measurement method is well-known in the industry. Shenzhen Ruiguang Kangtai Technology Co., Ltd. is a high-tech enterprise specialized in research and development, production and sales of laser technology and blood pressure measurement technology. It has a scientific research team, which provides strong technical support for independent research and development and upgrading of products. Pulse wave blood pressure measurement, the fourth generation of accurate blood pressure measurement technology independently developed by the company, has obtained Chinese invention patent (Patent No.: zl201010247968.6), Japanese invention patent (Patent No.: Chartered No.: 5591404) and Korean invention patent (Patent No.: 10-1460922), and applied for invention patent in more than 40 countries in the world. In China, the pulse wave blood pressure measurement method has passed the clinical verification in more than 20 large-scale third-class hospitals, including Beijing Fuwai Hospital, Tongji Medical College Affiliated to Huazhong University of science and technology. The "daily blood pressure" health management client developed by the group integrates advanced Internet technology and provides professional blood pressure health management services for customers based on accurate data of pulse wave sphygmomanometer. At the same time, sphygmomanometer products have been registered with 8 models and nearly 20 models. The specification covers hospital use, OTC, mobile use and children's use. In the past seven years, Ruiguang Kangtai has continuously expanded its market, established marketing networks in more than 20 provinces and cities in China, such as Guangzhou and Beijing. In the international market, semiconductor laser therapy machines and pulse wave sphygmomanometers have passed the CE certification of the European Union, exported to more than 20 countries and regions, such as the United States and Spain.

本文链接: https://brand.waitui.com/76a6090d8.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

大型科技股盘前多数上涨,特斯拉涨超1%

36氪获悉,大型科技股盘前多数上涨,截至发稿,特斯拉涨超1%,谷歌涨0.95%,苹果涨0.69%,Meta涨0.43%,奈飞涨0.34%,亚马逊涨0.27%,英伟达涨0.13%;微软跌0.65%。

25分钟前

热门中概股美股盘前多数上涨, 爱奇艺涨超3%

36氪获悉,热门中概股美股盘前多数上涨, 截至发稿,爱奇艺涨超3%,老虎证券、叮咚买菜涨超2%,富途控股、蔚来涨超1%,小鹏汽车涨0.33%;理想汽车、京东跌超1%。

25分钟前

东方财富:股东沈友根询价转让初步定价为21.66元/股

36氪获悉,东方财富发布公告,公司股东沈友根询价转让初步确定的转让价格为21.66元/股。此次询价转让拟转让股份已获全额认购,初步确定受让方为17家机构投资者,拟受让股份总数为1.588亿股。

25分钟前

蔚能与光谷智造园、湖北科投分别达成战略合作

36氪获悉,据蔚能官微,7月21日,武汉蔚能电池资产有限公司(简称“蔚能”)与武汉光谷智能制造产业园建设服务中心(简称“光谷智造园”)、湖北省科技投资集团有限公司(简称“湖北科投”)分别达成战略合作,各方将在电池资产管理、产业投资、资本市场等多维度深化合作。公司重要股东湖北科投在蔚能C轮融资中进一步加码。

25分钟前

有方科技:拟签订40亿元服务器采购合同,用于开展算力云服务业务

36氪获悉,有方科技发布公告,公司拟向多家供应商采购服务器,采购合同总金额预计不超过人民币40亿元。具体设备型号及其他详细信息公司出于商业秘密及市场竞争的考虑进行豁免披露登记。本次合同的签订属于公司日常经营行为,公司采购服务器主要用于向客户提供算力云服务业务。此外,公司开展算力云服务业务后,预期对公司未来财务状况和经营成果产生积极影响,不存在损害公司及全体股东利益的情形。

25分钟前

本页详细列出关于脉搏波maibobo的品牌信息,含品牌所属公司介绍,脉搏波maibobo所处行业的品牌地位及优势。
咨询